What is Fibrous Dysplasia

Fibrous dysplasia is a rare, non-hereditary skeletal disorder where normal bone is replaced by fibrous scar-like tissue, leading to weakened, misshapen, or painful bones. While it can affect any part of the skeleton, it most commonly involves the skull, facial bones, ribs, and long bones of the arms and legs. Because the condition varies significantly from person to person, management is highly individualized and focuses on pain control and preventing fractures.

What exactly happens to the bones in Fibrous Dysplasia?

In fibrous dysplasia, the body’s bone-building cells (osteoblasts) fail to mature correctly due to a genetic mutation. Instead of forming strong, mineralized bone, these cells produce an immature, soft, fibrous matrix. This abnormal tissue is structurally weak and prone to bending (deformity) or breaking (fracture). The condition is not a form of cancer, though it can cause significant physical symptoms depending on which bones are affected and how much of the skeleton is involved.

What are the different types of Fibrous Dysplasia?

Clinical classification of fibrous dysplasia is generally based on the extent of skeletal involvement:

• Monostotic Fibrous Dysplasia: This is the most common form, where the condition is limited to a single bone. It typically stops progressing after puberty.


• Polyostotic Fibrous Dysplasia: This form affects multiple bones. It is often more severe and may be associated with systemic issues.


• McCune-Albright Syndrome: A complex form of fibrous dysplasia characterized by the combination of polyostotic bone lesions, "café-au-lait" skin pigmentation, and endocrine (hormonal) abnormalities.

How common is Fibrous Dysplasia and who is affected?

Fibrous dysplasia is considered a rare disease, though exact prevalence remains difficult to pinpoint because many mild, monostotic cases may go undiagnosed. Current estimates suggest an incidence of approximately 1 in 5,000 to 1 in 10,000 people. It affects both males and females equally, and there is no known geographic, ethnic, or racial predisposition. While symptoms often emerge during childhood or adolescence, the condition is present from birth due to a post-zygotic mutation in the GNAS gene, which occurs randomly and is not passed from parent to child.

What differentiates Fibrous Dysplasia from other conditions?

Unlike osteoporosis, which involves a loss of bone density, fibrous dysplasia is a developmental issue of bone architecture. It is distinct from bone cancer in that it is benign and generally does not spread. A key clinical marker is the presence of the GNAS mutation, which distinguishes it from other fibro-osseous lesions. Our community at DiseaseMaps.org, which includes 280 individuals living with this condition, emphasizes that while the diagnosis can feel overwhelming, advancements in orthopedic management have significantly improved quality of life for many patients.

Next steps

• Consult an orthopedic surgeon or an endocrinologist who specializes in metabolic bone diseases.


• Request imaging (such as X-rays, CT, or MRI) to determine the full extent of skeletal involvement.


• Join the DiseaseMaps.org community to connect with other patients and share experiences regarding symptom management.


• Monitor for new pain or changes in bone shape, as these should be evaluated promptly by your medical team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult a qualified healthcare provider for diagnosis and treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Fibrous Dysplasia


• Orphanet: Fibrous Dysplasia of Bone


• OMIM (Online Mendelian Inheritance in Man): Polyostotic Fibrous Dysplasia


• Fibrous Dysplasia Foundation: Clinical Guidelines and Patient Resources